This is particularly relevant in the post-‘GIST era,’ where advances in diagnostic tools, especially the immunostaining of KIT protein by Hirota et al. in 1998, led to the reclassification of most stromal tumors as GISTs rather than LMSs [4]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.